COMMUNIQUÉS West-GlobeNewswire

Wave Life Sciences Announces Proposed Public Offering of Ordinary Shares
23/01/2019
CAMBRIDGE, Mass., Jan. 23, 2019 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a genetic medicines company focused on delivering transformational therapies for patients with serious, genetically-defined [...]
Conformis to Host Fourth Quarter and Fiscal Year 2018 Financial Results Webcast on February 6, 2019
23/01/2019
BILLERICA, Mass., Jan. 23, 2019 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ: CFMS) announced today that it will host a webcast on Wednesday, February 6, 2019, at 4:30 p.m. Eastern Time to discuss its financial results [...]
HTG Molecular Appoints Dr. Joseph Sparano as Lead of Its Clinical Scientific Advisory Board for Breast Cancer Program
23/01/2019
TUCSON, Ariz., Jan. 23, 2019 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics , Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, today announced it has appointed Dr. Joseph [...]
Bio-Path Holdings, Inc. Announces Closing of $1.7 Million Registered Direct Offering Priced At-the-Market
23/01/2019
HOUSTON, Jan. 23, 2019 (GLOBE NEWSWIRE) -- Bio-Path Holdings, Inc. (Nasdaq: BPTH) (Bio-Path), a biotechnology company leveraging its proprietary DNAbilize® antisense RNAi nanoparticle technology to develop a portfolio [...]
Revive Provides an Update on the Non-Brokered Private Placement
23/01/2019
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR RELEASE OR DISSEMINATION DIRECTLY, OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES TORONTO, Jan. 23, 2019 (GLOBE NEWSWIRE) -- Revive Therapeutics [...]
62 Genesis HealthCare Facilities Identified by U.S. News & World Report as Best Nursing Homes for 2018-2019
23/01/2019
KENNETT SQUARE, Pa., Jan. 23, 2019 (GLOBE NEWSWIRE) -- Genesis HealthCare , one of the largest post-acute care providers in the United States, today announced that 62 of its skilled nursing facilities were identified as [...]
Biocartis Group NV: BIOCARTIS SUCCESSFULLY RAISES EUR 55.50 MILLION
23/01/2019
PRESS RELEASE: REGULATED INFORMATION - INSIDE INFORMATION 23 January 2019, 21:30 CET BIOCARTIS SUCCESSFULLY RAISES EUR 55.50 MILLION IN AN EQUITY PLACEMENT Mechelen, Belgium , 23 January 2019 - Biocartis Group NV (the " [...]
Microbot Medical Inc. Announces $2.5 Million Registered Direct Offering Priced At-the-Market
23/01/2019
HINGHAM, Mass., Jan. 23, 2019 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), a medical device company specializing in the design and development of transformational micro-robotic medical technologies, today [...]
CORRECTING and REPLACING – Aurora Spine Announces New Patent for Its Minimally Invasive Spinal Implants Allowed by the United States Patent Office
23/01/2019
CARLSBAD, Calif., Jan. 23, 2019 (GLOBE NEWSWIRE) -- In a release issued under the same headline earlier today by Aurora Spine Corporation (TSXV: ASG) please note that “Expendable Interspinous Device" has been changed to [...]
The Biggest CBD-Infused Beverage Trends for 2019 and the Stocks Involved
23/01/2019
VANCOUVER, British Columbia, Jan. 23, 2019 (GLOBE NEWSWIRE) -- With the success of the 2018 Farm Bill in the rearview, investors are already setting their sights on what’s next: CBD-infused beverages. CBD-infused coffee [...]
Easton Announces Completion of Financial Statements With $200,000 in Sales in Quarter Ending Sept. 30th, 2018 and Revenue for Quarter Ending December 31, 2018
23/01/2019
TORONTO, ON, Jan. 23, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Easton Pharmaceuticals Inc. (OTC: EAPH ) announces completion of its financial statements with $200,000 in sales in its quarter ending September 30 th [...]
BLVD Centers Announces Support for Medical Cannabis Research
23/01/2019
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. ALL FIGURES IN CANADIAN DOLLARS UNLESS OTHERWISE SPECIFIED. LOS ANGELES, Jan. 23, 2019 (GLOBE NEWSWIRE) -- BLVD Centers [...]
BLVD Centers Announces Support for Medicial Cannabis Research
23/01/2019
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. ALL FIGURES IN CANADIAN DOLLARS UNLESS OTHERWISE SPECIFIED. LOS ANGELES, Jan. 23, 2019 (GLOBE NEWSWIRE) -- BLVD Centers [...]
Changes to Zealand Pharma’s Executive Management
23/01/2019
Company announcement – No. 1/2019 Changes to Zealand Pharma’s Executive Management Copenhagen, Denmark, January 23, 2019 – Zealand Pharma A/S today announced changes to its Executive Management. Following the [...]
Biocartis Group NV: BIOCARTIS UPSIZES ITS EQUITY PLACEMENT DUE TO SIGNIFICANT DEMAND
23/01/2019
PRESS RELEASE : REGULATED INFORMATION - INSIDE INFORMATION 23 January 2019, 17:15 CET BIOCARTIS UPSIZES ITS EQUITY PLACEMENT DUE TO SIGNIFICANT DEMAND Mechelen, Belgium , 23 January 2019 - Biocartis Group NV (the " [...]
‘Sleep Normal’ campaign urges Americans to end frequent nighttime urination and stop settling for nights of bad sleep
23/01/2019
Nearly 50 million Americans wake up to urinate more than once per night due to a treatable medical condition called nocturia WASHINGTON, Jan. 23, 2019 (GLOBE NEWSWIRE) -- A new awareness campaign called ‘Sleep Normal’ [...]
Selecta Biosciences Announces Pricing of Public Offering of Common Stock
23/01/2019
WATERTOWN, Mass., Jan. 23, 2019 (GLOBE NEWSWIRE) -- Selecta Biosciences, Inc. (Nasdaq: SELB) (“Selecta”), a clinical-stage biotechnology company focused on unlocking the full potential of biologic therapies based on its [...]
eSight Corp. Appoints Kevin Banderk to Chief Commercial Officer
23/01/2019
TORONTO, Jan. 23, 2019 (GLOBE NEWSWIRE) -- eSight , creators of the world's most advanced sight-enhancing glasses for the visually impaired, is pleased to announce the appointment of Kevin Banderk to the position of [...]
Long-term survival analysis of the randomised Phase III study shows a clear clinical benefit of inolimomab in SR-aGvHD
23/01/2019
Long-term survival analysis of the randomised Phase III study shows a clear clinical benefit of inolimomab in SR-aGvHD Follow-up of INO-107 Phase III study patients up to 8.5 years is the first long term analysis of a [...]

Pages